Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Urology-Nephrology
12. November 2026
Search
medline.ch
Urology-Nephrology
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Inflammation-Infection
Nephrolithiasis
Renal Failure
Sexuality
Neoplasia/BPH
Others
Rect Top
Anzeige
Zoom:
Page 1 of 24257
Articles 1 - 20 / 485137
A Validated Artificial Intelligence Model Versus Urinary Supersaturation Alone for Predicting Kidney Stone Composition.
Mayo Clin Proc
Lantz EB, Vanderboom P, Koo K, Jannetto PJ, Lieske JC, Meeusen J, Day PL.
PMID: 43018532 [PubMed - as supplied by publisher]
Estimated lifetime harms and benefits of continuing biennial prostate cancer screening in older men by comorbidity group.
Cancer
Gulati R, Suresh K, Psutka SP, Taylor JMG, Owens L, Tsodikov A, Walter LC, Etzioni R.
PMID: 43018390 [PubMed - indexed for MEDLINE]
Biomarker use in the prostate cancer screening pathway: Maps of the evidence.
Cancer
Shiau RL, Griffin JC, Troutman CAB, Relevo R, Kondo KK.
PMID: 43018379 [PubMed - indexed for MEDLINE]
Prostate-specific antigen-based screening for prostate cancer: A systematic review to inform an American Cancer Society guideline.
Cancer
Griffin JC, Shiau RL, Troutman CAB, Welsh A, Edwards E, Ajayi IA, Relevo R, Kondo KK.
PMID: 43018378 [PubMed - indexed for MEDLINE]
American Cancer Society guideline for the early detection of prostate cancer, 2026.
CA Cancer J Clin
Hoffman RM, Wolf AMD, Etzioni RD, Oeffinger KC, Raoof S, Walter LC, Zeigler-Johnson C, Church TR, Jones CK, Shelton AL, Elkin EB, Guerra CE, Perkins RB, Shih YT, Skates SJ, Gulati R, Katki HA, Kratzer TB, Manassaram-Baptiste D, Dahut WL, Smith RA.
PMID: 43018083 [PubMed - indexed for MEDLINE]
Use of pumpkin seed (Cucurbita pepo) versus placebo and versus alpha-blockers in the management of benign prostatic hyperplasia: a systematic review and meta-analysis of randomized controlled trials.
Acta Cir Bras
Benedicto BC, Constantinou BT, Leite Junior AM, Orra SH, Molina BS, Almeida TPL, Navas BBDS, Sardenberg RADS, Almeida FG, Maia RS, Cruz JASD.
PMID: 43018017 [PubMed - indexed for MEDLINE]
Assessment of physical activity level and quality of life in patients with chronic kidney disease in stages 3b and 4.
Braz J Med Biol Res
Santos FTD, Santos CGS, Barreto FC, Fernandez R.
PMID: 43018011 [PubMed - indexed for MEDLINE]
The future of prostate cancer screening: from prostate-specific antigen to smart, risk-adapted pathways.
Curr Opin Urol
Zhang DZ, Carson DS, Tosoian JJ.
PMID: 43017916 [PubMed - as supplied by publisher]
Long-term outcomes of biodegradable- versus durable-polymer drug-eluting stents in patients with advanced chronic kidney disease undergoing percutaneous coronary intervention: a 7-year retrospective cohort study.
Coron Artery Dis
Yeh JK, Huang MS, Chang HY, Lee WH, Liu PY, Liu YW.
PMID: 43017910 [PubMed - as supplied by publisher]
Peritesticular xanthogranuloma mimicking testicular cancer: case report.
Ann Med Surg (Lond)
Ageze AE, Bekele HA, Atalay AA, Getahun GA.
PMID: 43017659 [PubMed]
Reviewed article: Biase, TMMA; Silva, MT; Galvão, TF. Selective reporting of adverse renal reactions associated with selective cyclooxygenase-2 inhibitors in randomized clinical trials: a cross-sectional study, 2023. Epidemiol Serv Saude. 2026:35;e20260191.
Epidemiol Serv Saude
Lima VG.
PMID: 43017636 [PubMed - in process]
Selective reporting of adverse renal reactions associated with selective cyclooxygenase-2 inhibitors in randomized clinical trials: a cross-sectional study, 2023.
Epidemiol Serv Saude
Biase TMMA, Silva MT, Galvão TF.
PMID: 43017626 [PubMed - indexed for MEDLINE]
Reviewed article: Biase, TMMA; Silva, MT; Galvão, TF. Selective reporting of adverse renal reactions associated with selective cyclooxygenase-2 inhibitors in randomized clinical trials: a cross-sectional study, 2023. Epidemiol Serv Saude. 2026:35;e20260191.
Epidemiol Serv Saude
de Padua CM.
PMID: 43017617 [PubMed - in process]
Using secure WhatsApp-based digital recruitment as an intervention in prostate cancer research with black men.
Front Digit Health
Wakeham K, Theodorakopoulos G, Li S, Liu Y, Wang X, Courtier N, Quinn-Scoggins H, Fry S.
PMID: 43017497 [PubMed]
Translating the pathophysiology of sepsis-associated acute kidney injury: From bench to bedside.
J Intensive Med
Lu M, Zhang Q, Pang M, Wang H, Zhang M, Li Y, Wang H.
PMID: 43017485 [PubMed]
Kidney-compartment genomic prioritization across diabetic and population kidney traits: an exploratory Mendelian randomization and colocalization study.
Front Genet
Chen R, Bi X.
PMID: 43017455 [PubMed]
Determining the optimal cutoff value of prostate-specific antigen density for diagnosing prostate cancer in 50-80-year-old patients undergoing prostate biopsy with PSA levels of 4-10Â ng/mL.
Ann Med Surg (Lond)
Jamshidi N, Akbarzadehpasha A, Bijani A, Rajabalian MB, Hosseini SM, Moudi E.
PMID: 43017375 [PubMed]
Non-hormonal pharmacological treatments for benign prostatic obstruction: a systematic review of trials published between 2005 and 2025.
Front Surg
Diong J, Ong A, Dassanayake SN, Wong A, McCauley N, Tzelves L, Juliebø-Jones P, Somani BK.
PMID: 43017340 [PubMed]
Reviewed article: Biase, TMMA; Silva, MT; Galvão, TF. Selective reporting of adverse renal reactions associated with selective cyclooxygenase-2 inhibitors in randomized clinical trials: a cross-sectional study, 2023. Epidemiol Serv Saude. 2026:35;e20260191.
Epidemiol Serv Saude
Guimarães NS.
PMID: 43017315 [PubMed - in process]
Endometrial preparation for embryo transfer: reproductive outcomes of modified natural cycle versus hormone replacement therapy.
Rev Bras Ginecol Obstet
de Sá LC, Fagundes LS, Lamaita RM, Cota AMM.
PMID: 43017256 [PubMed - indexed for MEDLINE]
Articles 1 - 20 / 485137
Page 1 of 24257
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy